|
A more recent version of this article appeared on March 1, 2007
Papers In Press, published online ahead of print November 26, 2006
J. Lipid Res., doi:10.1194/jlr.M600404-JLR200
Submitted on September 12, 2006
Revised on October 23, 2006
Accepted on November 25, 2006
Cholesterol import fails to prevent catalyst-based inhibition of ergosterol synthesis and cell proliferation of Trypanosoma brucei
Wenxu Zhou, George A. M. Cross, and W. David Nes
Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409
Corresponding Author: wdavid.nes{at}ttu.edu
Trypanosoma brucei (TB) cultured in rat blood, bovine serum or lipid-depleted serum generated distinct differences in cholesterol availability. Whereas cell proliferation of the parasite was relatively unaffected by cholesterol availability, the ratios of cellular ergostenols to cholesterol varied from close to unity to three orders of magnitude different with cholesterol the major sterol (> 99%) of bloodstream form cells. In the procyclic form cultured with lipid-depleted serum, 15 sterols at 52 fg/cell were identified by GC-MS. The structure of these sterols reveal a non-conventional ergosterol pathway consistent with the novel product diversity catalyzed by the recently cloned sterol methyltransferase (SMT). A potent transition state analog of the TB SMT C24-alkylation reaction, 25-azalanosterol [Ki 39 nM], was found to inhibit the growth of the procyclic and bloodstream forms at an IC50 of ca. 1 µM. This previously unrecognized catalyst-specific inhibition of cell growth was unmasked further using 25-azalanosterol-treated procyclic form which, compared to control cultures, causes a change in cellular sterol content from ergostenols to cholesterol. However, growth of the blood stream form disrupted by 25-azalanosterol is not rescued by cholesterol absorption from the host, suggesting an essential role for ergosterol (24-methyl sterol) in cell proliferation and that the SMT can be a new enzyme target for drug design.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. I. Lepesheva, H.-W. Park, T. Y. Hargrove, B. Vanhollebeke, Z. Wawrzak, J. M. Harp, M. Sundaramoorthy, W. D. Nes, E. Pays, M. Chaudhuri, et al.
Crystal Structures of Trypanosoma brucei Sterol 14{alpha}-Demethylase and Implications for Selective Treatment of Human Infections
J. Biol. Chem.,
January 15, 2010;
285(3):
1773 - 1780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fridberg, C. L. Olson, E. S. Nakayasu, K. M. Tyler, I. C. Almeida, and D. M. Engman
Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei
J. Cell Sci.,
February 15, 2008;
121(4):
522 - 535.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|